These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

469 related articles for article (PubMed ID: 26968275)

  • 1. Comparison of tuberculin skin test and quantiferon-TB gold in tube test for diagnosis of latent tuberculosis infection in health care workers: A cross sectional study.
    Bozkanat E; Kaya H; Sezer O; Caliskan T; Kilic E; Ciftci F; Gumus S; Kartaloglu Z
    J Pak Med Assoc; 2016 Mar; 66(3):270-4. PubMed ID: 26968275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-employment screening of latent tuberculosis infection among healthcare workers using tuberculin skin test and QuantiFERON-TB Gold test at a tertiary care hospital in Saudi Arabia.
    El-Helaly M; Khan W; El-Saed A; Balkhy HH
    J Infect Public Health; 2014; 7(6):481-8. PubMed ID: 25194817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance of QuantiFERON TB gold test compared with the tuberculin skin test for detecting latent tuberculosis infection in lung and heart transplant candidates.
    Mardani M; Farshidpour M; Nekoonam M; Varahram F; Najafizadeh K; Mohammadi N; Sharifkashani B; Gachkar L; Farokhzad B; Droudinia A; Javanmard P; Tabarsi P
    Exp Clin Transplant; 2014 Apr; 12(2):129-32. PubMed ID: 24702145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence of latent tuberculosis infection in BCG-vaccinated healthcare workers by using an interferon-gamma release assay and the tuberculin skin test in an intermediate tuberculosis burden country.
    Hung WT; Lee SS; Sy CL; Wu KS; Chen JK; Tsai HC; Chen YS
    J Microbiol Immunol Infect; 2015 Apr; 48(2):147-52. PubMed ID: 24071516
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon-γ release assays and tuberculin skin testing for diagnosis of latent tuberculosis infection in healthcare workers in the United States.
    Dorman SE; Belknap R; Graviss EA; Reves R; Schluger N; Weinfurter P; Wang Y; Cronin W; Hirsch-Moverman Y; Teeter LD; Parker M; Garrett DO; Daley CL;
    Am J Respir Crit Care Med; 2014 Jan; 189(1):77-87. PubMed ID: 24299555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of healthcare workers for latent tuberculosis infection in the low tuberculosis burden country: QuantiFERON-TB gold in tube test or tuberculin skin test?
    Keshavarz Valian S; Mahmoudi S; Pourakbari B; Abdolsalehi MR; Eshaghi H; Mamishi S
    Arch Environ Occup Health; 2019; 74(3):109-114. PubMed ID: 30516445
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The evaluation of the utility of QuantiFERON TB-Gold In-Tube; QFT-GIT].
    Matsumoto T; Yamazaki T
    Kekkaku; 2014 Sep; 89(9):743-55. PubMed ID: 25730946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of latent tuberculosis infection among pre-clinical and clinical medical students using QuantiFERON-TB gold plus and tuberculin skin test at a teaching hospital in Thailand: A cross-sectional study.
    Chumpa N; Kawkitinarong K; Wongpiyabovorn J; Paitoonpong L; Suwanpimolkul G
    J Infect Public Health; 2022 Apr; 15(4):400-405. PubMed ID: 35325687
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of QuantiFERON-TB Gold In-Tube versus tuberculin skin test for diagnosis and treatment of Latent Tuberculosis Infection in primary health care workers in Brazil.
    Loureiro RB; Maciel ELN; Caetano R; Peres RL; Fregona G; Golub JE; Braga JU
    PLoS One; 2019; 14(11):e0225197. PubMed ID: 31725786
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tuberculin and QuantiFERON-TB-Gold tests for latent tuberculosis: a meta-analysis.
    Doosti-Irani A; Ayubi E; Mostafavi E
    Occup Med (Lond); 2016 Aug; 66(6):437-445. PubMed ID: 27121635
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for tuberculosis infection in spanish healthcare workers: Comparison of the QuantiFERON-TB gold in-tube test with the tuberculin skin test.
    Alvarez-León EE; Espinosa-Vega E; Santana-Rodríguez E; Molina-Cabrillana JM; Pérez-Arellano JL; Caminero JA; Serrano-Aguilar P
    Infect Control Hosp Epidemiol; 2009 Sep; 30(9):876-83. PubMed ID: 19614541
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N; Zehra Aydin S; Inanc N; Karakurt S; Direskeneli H; Yavuz S
    Lupus; 2012 Apr; 21(5):491-5. PubMed ID: 22140142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of latent tuberculosis infection among healthcare workers in China as detected by two interferon-gamma release assays.
    Wei Z; Yang M; Quan B; Wang Y; Wu Y; Ji B
    J Hosp Infect; 2013 Aug; 84(4):323-5. PubMed ID: 23806839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of tuberculin skin testing and QuantiFERON-TB Gold-In Tube test in health care workers.
    Cağlayan V; Ak O; Dabak G; Damadoğlu E; Ketenci B; Ozdemir M; Ozer S; Saygı A
    Tuberk Toraks; 2011; 59(1):43-7. PubMed ID: 21554229
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Usefulness of Quantiferon-TB Gold in Tube® in screening for latent tuberculosis infection in health workers].
    Martinez-Lacasa X; Font R; Gonzalez S; Sallent S; Jaen A; Lite J; Cuchi E
    Enferm Infecc Microbiol Clin; 2015 Oct; 33(8):525-31. PubMed ID: 25613557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis of latent tuberculosis infection before initiation of anti-tumor necrosis factor therapy using both tuberculin skin test and QuantiFERON-TB Gold In Tube assay.
    Kim HC; Jo KW; Jung YJ; Yoo B; Lee CK; Kim YG; Yang SK; Byeon JS; Kim KJ; Ye BD; Shim TS
    Scand J Infect Dis; 2014 Nov; 46(11):763-9. PubMed ID: 25195652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The performance of quantiferon-TB gold in-tube (QFT-IT) test compared to tuberculin skin test (TST) in detecting latent tuberculosis infection (LTBI) in the presence of HIV coinfection in a high TB-burden area with BCG-vaccinated population.
    James PM; Ganaie FA; Kadahalli RL
    J Int Assoc Provid AIDS Care; 2014; 13(1):47-55. PubMed ID: 23482341
    [TBL] [Abstract][Full Text] [Related]  

  • 18. QuantiFERON-TB Gold and the TST are both useful for latent tuberculosis infection screening in autoimmune diseases.
    Bartalesi F; Vicidomini S; Goletti D; Fiorelli C; Fiori G; Melchiorre D; Tortoli E; Mantella A; Benucci M; Girardi E; Cerinic MM; Bartoloni A
    Eur Respir J; 2009 Mar; 33(3):586-93. PubMed ID: 19047313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of QuantiFERON-TB Gold In-Tube Test and tuberculin skin test for identification of latent Mycobacterium tuberculosis infection in healthcare staff and association between positive test results and known risk factors for infection.
    Vinton P; Mihrshahi S; Johnson P; Jenkin GA; Jolley D; Biggs BA
    Infect Control Hosp Epidemiol; 2009 Mar; 30(3):215-21. PubMed ID: 19191484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interferon-gamma release assays and tuberculin skin testing for diagnosing latent Mycobacterium tuberculosis infection in at-risk groups in Poland.
    Kruczak K; Mastalerz L; Sładek K
    Int J Mycobacteriol; 2016 Mar; 5(1):27-33. PubMed ID: 26927987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.